Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Behjatolah Karbassi

Concepts (272)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antigens, Tumor-Associated, Carbohydrate
15
2023
24
3.680
 Why?
Cancer Vaccines
13
2022
78
2.510
 Why?
Peptides
17
2022
229
2.430
 Why?
Carbohydrates
14
2009
41
2.270
 Why?
Molecular Mimicry
13
2007
36
1.930
 Why?
Breast Neoplasms
12
2024
1206
1.650
 Why?
Neoplasms
9
2022
1305
1.410
 Why?
Immunotherapy
6
2022
244
1.060
 Why?
Epitopes, T-Lymphocyte
6
2009
26
0.860
 Why?
HIV Envelope Protein gp120
4
2009
13
0.800
 Why?
Antibodies, Neoplasm
2
2017
27
0.780
 Why?
Lung Neoplasms
4
2014
636
0.780
 Why?
HIV-1
4
2009
59
0.770
 Why?
Mice, Inbred BALB C
16
2011
312
0.760
 Why?
Antigens
4
2003
41
0.740
 Why?
Animals
31
2023
13523
0.630
 Why?
Epithelial-Mesenchymal Transition
2
2020
58
0.620
 Why?
Clinical Trials, Phase I as Topic
2
2017
25
0.600
 Why?
Gene Expression Regulation, Neoplastic
5
2020
858
0.590
 Why?
Vaccines, DNA
6
2006
11
0.590
 Why?
Immunologic Surveillance
2
2009
10
0.580
 Why?
HIV Antigens
3
2006
9
0.560
 Why?
Epitopes
3
2009
65
0.550
 Why?
Cell Transformation, Neoplastic
1
2018
184
0.540
 Why?
Antineoplastic Agents
3
2017
1222
0.510
 Why?
Immunity, Innate
3
2018
117
0.510
 Why?
Neoplasm Proteins
1
2018
334
0.490
 Why?
Molecular Targeted Therapy
1
2017
134
0.490
 Why?
Mice
20
2011
5965
0.480
 Why?
Cell Hypoxia
1
2015
83
0.460
 Why?
Biomimetic Materials
1
2014
11
0.460
 Why?
Estrogen Receptor alpha
1
2015
85
0.450
 Why?
Epigenesis, Genetic
1
2018
407
0.450
 Why?
Vaccines
4
2002
51
0.430
 Why?
T-Lymphocytes
7
2010
340
0.420
 Why?
Cross Reactions
8
2006
41
0.420
 Why?
Oligosaccharides
4
2007
34
0.420
 Why?
Amino Acid Sequence
9
2006
591
0.420
 Why?
Molecular Sequence Data
9
2006
792
0.410
 Why?
Sarcoma, Experimental
2
2004
14
0.410
 Why?
Antigens, Neoplasm
5
2007
147
0.400
 Why?
Polysaccharides
2
2011
56
0.400
 Why?
Humans
35
2024
52336
0.400
 Why?
AIDS Vaccines
3
2009
11
0.380
 Why?
Plant Lectins
2
2010
8
0.380
 Why?
Isoflavones
1
2023
88
0.380
 Why?
Sulfotransferases
3
2020
38
0.370
 Why?
Chondroitin Sulfates
2
2011
14
0.360
 Why?
Soybean Proteins
1
2023
162
0.360
 Why?
P-Selectin
2
2011
30
0.360
 Why?
CD8-Positive T-Lymphocytes
3
2007
132
0.350
 Why?
Autoantigens
1
2011
53
0.350
 Why?
Fructose
1
2010
22
0.340
 Why?
Carbon
1
2010
55
0.340
 Why?
Adaptive Immunity
1
2010
33
0.340
 Why?
CD4-Positive T-Lymphocytes
3
2006
165
0.320
 Why?
Vaccines, Subunit
3
2006
15
0.320
 Why?
Obesity
2
2023
1162
0.310
 Why?
Drug Delivery Systems
1
2010
146
0.300
 Why?
Carcinoma, Ductal
1
2008
7
0.300
 Why?
Proteoglycans
3
2023
87
0.290
 Why?
Mammary Neoplasms, Experimental
2
2005
122
0.280
 Why?
Interferon-gamma
4
2018
179
0.280
 Why?
Carcinoma in Situ
1
2008
72
0.280
 Why?
Cell Line, Tumor
6
2011
1436
0.280
 Why?
Dendritic Cells
3
2005
136
0.270
 Why?
T-Lymphocytes, Cytotoxic
5
2009
66
0.260
 Why?
Female
18
2024
28105
0.260
 Why?
Concanavalin A
2
2005
11
0.240
 Why?
Sarcoma
1
2006
72
0.240
 Why?
Mammary Neoplasms, Animal
1
2005
33
0.240
 Why?
HIV Infections
1
2009
388
0.240
 Why?
Ligands
5
2011
207
0.230
 Why?
MCF-7 Cells
4
2020
62
0.230
 Why?
Neoplasm Metastasis
5
2015
240
0.230
 Why?
Magnetic Resonance Spectroscopy
1
2005
253
0.220
 Why?
Acetylglucosamine
1
2004
7
0.220
 Why?
Histocompatibility Antigens Class I
1
2004
48
0.220
 Why?
Combined Modality Therapy
2
2017
636
0.210
 Why?
Melanoma
1
2007
280
0.210
 Why?
Immunoglobulin G
2
2003
195
0.210
 Why?
Immunotherapy, Active
1
2003
4
0.210
 Why?
Peptide Fragments
1
2004
203
0.200
 Why?
Peptide Library
4
2005
16
0.200
 Why?
Glycosylation
3
2010
106
0.200
 Why?
Autoantibodies
2
2018
121
0.200
 Why?
Cell Proliferation
4
2020
1029
0.190
 Why?
Antigens, Viral
1
2002
43
0.190
 Why?
Antibodies, Monoclonal
5
2023
481
0.190
 Why?
Apoptosis
2
2020
1127
0.190
 Why?
Biochemistry
1
2001
6
0.180
 Why?
Liver Neoplasms
1
2005
332
0.180
 Why?
Enzyme-Linked Immunosorbent Assay
3
2010
236
0.180
 Why?
Cell Adhesion
3
2006
164
0.170
 Why?
Carbamates
1
2020
16
0.170
 Why?
CHO Cells
3
2006
125
0.170
 Why?
Cricetinae
3
2006
194
0.170
 Why?
Adjuvants, Immunologic
2
2014
52
0.170
 Why?
Colchicine
1
2020
24
0.170
 Why?
Antineoplastic Agents, Phytogenic
1
2020
71
0.160
 Why?
Neoplastic Stem Cells
1
2020
93
0.160
 Why?
Carcinoma, Ductal, Breast
1
2020
89
0.160
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2020
91
0.150
 Why?
Anthroposophy
1
2018
1
0.150
 Why?
Flow Cytometry
3
2006
404
0.150
 Why?
Tumor Microenvironment
2
2024
255
0.150
 Why?
Tumor Cells, Cultured
3
2015
456
0.150
 Why?
Antibody Formation
3
2003
51
0.150
 Why?
Cell Division
3
2006
291
0.150
 Why?
Gene-Environment Interaction
1
2018
40
0.150
 Why?
Immunization
3
2004
68
0.140
 Why?
Chondroitin Sulfate Proteoglycans
2
2023
18
0.140
 Why?
Immune Tolerance
2
2009
91
0.140
 Why?
Plant Extracts
1
2020
193
0.140
 Why?
Spleen
3
2004
173
0.140
 Why?
Cell Movement
4
2020
277
0.140
 Why?
Homeostasis
1
2018
206
0.130
 Why?
Clinical Trials, Phase II as Topic
1
2017
47
0.130
 Why?
Forecasting
1
2017
154
0.130
 Why?
HIV Antibodies
2
2006
15
0.120
 Why?
Models, Immunological
2
2007
8
0.120
 Why?
Membrane Proteins
2
2023
340
0.120
 Why?
Interleukin-12
2
2006
27
0.120
 Why?
Lectins
2
2006
14
0.120
 Why?
Phenotype
2
2010
799
0.120
 Why?
Coculture Techniques
1
2015
145
0.120
 Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2015
62
0.110
 Why?
Drug Therapy
1
2014
44
0.110
 Why?
Transforming Growth Factor beta
1
2015
139
0.110
 Why?
Antibodies
1
2014
152
0.110
 Why?
Adipocytes
1
2015
130
0.110
 Why?
Vaccines, Conjugate
2
2005
9
0.100
 Why?
Nuclear Proteins
1
2015
251
0.100
 Why?
Cell Separation
2
2005
74
0.100
 Why?
Scavenger Receptors, Class E
1
2015
204
0.100
 Why?
Rats, Zucker
1
2023
73
0.100
 Why?
Positron-Emission Tomography
1
2014
303
0.100
 Why?
Cytotoxicity, Immunologic
2
2005
58
0.100
 Why?
Protein Binding
2
2005
680
0.100
 Why?
Immunity, Cellular
2
2003
64
0.100
 Why?
Mice, Nude
2
2004
236
0.100
 Why?
Mutation
1
2018
1351
0.100
 Why?
Lymphocyte Activation
3
2001
172
0.090
 Why?
C-Reactive Protein
1
2023
155
0.090
 Why?
Kinetics
2
2005
623
0.090
 Why?
Injections, Intramuscular
2
2003
56
0.090
 Why?
Interleukin-6
1
2023
278
0.090
 Why?
Binding Sites
2
2003
379
0.090
 Why?
Prognosis
3
2020
2094
0.090
 Why?
Tumor Necrosis Factor-alpha
1
2023
397
0.090
 Why?
Microscopy, Phase-Contrast
1
2010
11
0.090
 Why?
Lung
1
2014
502
0.090
 Why?
Body Weight
1
2023
522
0.090
 Why?
Transfection
3
2007
372
0.090
 Why?
B-Lymphocytes
2
2002
185
0.090
 Why?
DNA Methylation
1
2015
592
0.080
 Why?
Antigens, CD
2
2003
219
0.080
 Why?
Substrate Specificity
1
2010
198
0.080
 Why?
Membrane Glycoproteins
2
2003
244
0.080
 Why?
Actins
1
2010
117
0.080
 Why?
Dose-Response Relationship, Drug
2
2005
1377
0.080
 Why?
Antibodies, Catalytic
1
2009
1
0.080
 Why?
Receptors, CCR5
1
2009
7
0.080
 Why?
Neoplasm Invasiveness
1
2010
278
0.080
 Why?
Cells, Cultured
2
2003
1589
0.080
 Why?
Time Factors
2
2005
2957
0.080
 Why?
Killer Cells, Natural
1
2009
116
0.070
 Why?
Fucosyltransferases
1
2007
5
0.070
 Why?
Glycosaminoglycans
1
2007
19
0.070
 Why?
Male
3
2023
26696
0.070
 Why?
Molecular Biology
1
2007
27
0.070
 Why?
Binding Sites, Antibody
1
2006
15
0.070
 Why?
Rats
1
2023
3202
0.070
 Why?
Amino Acid Motifs
1
2006
59
0.060
 Why?
Heparin
1
2007
88
0.060
 Why?
Cricetulus
1
2006
104
0.060
 Why?
Cell Membrane
1
2007
245
0.060
 Why?
Antineoplastic Agents, Alkylating
1
2006
77
0.060
 Why?
E-Selectin
1
2005
13
0.060
 Why?
Xenograft Model Antitumor Assays
1
2006
222
0.060
 Why?
Cyclophosphamide
1
2006
171
0.060
 Why?
Wheat Germ Agglutinins
1
2005
3
0.060
 Why?
Densitometry
1
2005
13
0.060
 Why?
Mannose
1
2005
16
0.060
 Why?
Hydrocarbons
1
2005
14
0.060
 Why?
Surface Plasmon Resonance
1
2005
19
0.060
 Why?
Methane
1
2005
11
0.060
 Why?
Phosphorylcholine
1
2005
20
0.060
 Why?
Bone Marrow Cells
1
2006
190
0.060
 Why?
Growth Inhibitors
1
2005
26
0.060
 Why?
Biosensing Techniques
1
2005
30
0.060
 Why?
Calcium
1
2007
375
0.060
 Why?
Immunoglobulins
1
2005
76
0.060
 Why?
Glycolysis
1
2005
73
0.060
 Why?
Genetic Variation
1
2006
230
0.060
 Why?
Oligonucleotide Array Sequence Analysis
1
2006
412
0.060
 Why?
Antigen Presentation
1
2004
26
0.060
 Why?
Bone Neoplasms
1
2006
184
0.050
 Why?
Treatment Outcome
1
2014
5407
0.050
 Why?
Cytosol
1
2004
81
0.050
 Why?
Endothelial Cells
1
2006
283
0.050
 Why?
Immunoglobulin Constant Regions
1
2003
3
0.050
 Why?
Plasmids
2
2003
167
0.050
 Why?
Recombinant Proteins
1
2005
491
0.050
 Why?
Middle Aged
2
2020
13014
0.050
 Why?
Histocompatibility Antigens Class II
1
2003
35
0.050
 Why?
Antibodies, Viral
1
2003
110
0.050
 Why?
Bacterial Capsules
1
2003
19
0.050
 Why?
DNA, Neoplasm
1
2003
146
0.050
 Why?
Immunoglobulin M
1
2003
60
0.050
 Why?
Th1 Cells
1
2003
55
0.050
 Why?
Carbohydrate Metabolism
1
2002
25
0.050
 Why?
Antibodies, Anti-Idiotypic
1
2002
25
0.050
 Why?
Models, Chemical
1
2002
66
0.050
 Why?
L-Selectin
1
2001
7
0.050
 Why?
Calorimetry
1
2001
6
0.050
 Why?
Carbohydrate Sequence
1
2001
10
0.050
 Why?
Epitope Mapping
1
2001
7
0.050
 Why?
Thermodynamics
1
2001
35
0.050
 Why?
Binding, Competitive
1
2001
90
0.050
 Why?
Mice, Inbred CBA
1
2001
37
0.040
 Why?
Protein Structure, Secondary
1
2001
71
0.040
 Why?
Sequence Homology, Amino Acid
1
2001
145
0.040
 Why?
Gene Expression Profiling
1
2006
1110
0.040
 Why?
Protein Conformation
1
2001
179
0.040
 Why?
Antibody-Dependent Cell Cytotoxicity
1
2000
12
0.040
 Why?
Injections, Intraperitoneal
1
2000
57
0.040
 Why?
Colchicum
1
2020
3
0.040
 Why?
Inhibitory Concentration 50
1
2020
74
0.040
 Why?
Models, Molecular
1
2001
352
0.040
 Why?
Drug Screening Assays, Antitumor
1
2020
136
0.040
 Why?
Child, Preschool
1
2008
4030
0.040
 Why?
H-2 Antigens
1
1999
4
0.040
 Why?
Wnt Signaling Pathway
1
2020
95
0.040
 Why?
Receptors, Estrogen
1
2020
132
0.040
 Why?
Transformation, Genetic
1
1998
17
0.040
 Why?
Glycoside Hydrolases
1
1998
18
0.040
 Why?
Clostridium
1
1998
17
0.040
 Why?
Cell Survival
1
2020
602
0.040
 Why?
Genes, Reporter
1
1998
88
0.040
 Why?
Plants
1
1998
30
0.040
 Why?
Models, Biological
1
2001
743
0.040
 Why?
Survival Rate
1
2020
940
0.030
 Why?
Adolescent
1
2008
6692
0.030
 Why?
Retrospective Studies
1
2008
6578
0.030
 Why?
Child
1
2008
7157
0.030
 Why?
CpG Islands
1
2015
121
0.030
 Why?
Disease Progression
1
2015
870
0.020
 Why?
RNA Interference
1
2011
186
0.020
 Why?
RNA, Small Interfering
1
2011
218
0.020
 Why?
Lymphocyte Subsets
1
2003
14
0.010
 Why?
Simian virus 40
1
2003
14
0.010
 Why?
Immunoglobulin Variable Region
1
2003
17
0.010
 Why?
Mutagenesis, Site-Directed
1
2003
98
0.010
 Why?
Sequence Deletion
1
2003
73
0.010
 Why?
Protein Structure, Tertiary
1
2003
252
0.010
 Why?
Recombinant Fusion Proteins
1
2003
179
0.010
 Why?
Down-Regulation
1
2003
347
0.010
 Why?
Up-Regulation
1
2003
462
0.010
 Why?
HIV Envelope Protein gp160
1
1999
2
0.010
 Why?
Radiation Chimera
1
1999
4
0.010
 Why?
Protein Engineering
1
1999
18
0.010
 Why?
beta 2-Microglobulin
1
1999
39
0.010
 Why?
Plants, Toxic
1
1998
10
0.010
 Why?
Enzyme Stability
1
1998
21
0.010
 Why?
Plants, Genetically Modified
1
1998
19
0.010
 Why?
Stem Cells
1
1999
182
0.010
 Why?
Hot Temperature
1
1998
200
0.010
 Why?
Signal Transduction
1
2003
1716
0.010
 Why?
Mice, Knockout
1
1999
909
0.010
 Why?
Mice, Inbred C57BL
1
1999
1903
0.010
 Why?
Muscle, Skeletal
1
1999
809
0.010
 Why?
Karbassi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (272) concept(s)
_
Co-Authors Expand Description
See all (9) people
_
Similar People Expand Description
See all (36) people
_
Same Department Expand Description
Search Department